会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 43. 发明授权
    • Immunoassay and immunometric assay of free ligand concentrations in
biological fluids
    • 生物液体中游离配体浓度的免疫测定和免疫测定
    • US4745072A
    • 1988-05-17
    • US705421
    • 1985-02-20
    • Roger P. EkinsThomas M. Jackson
    • Roger P. EkinsThomas M. Jackson
    • G01N33/536A61K39/00G01N33/53G01N33/543G01N33/78G01N33/534G01N33/546
    • G01N33/78G01N33/53Y10S436/804Y10S436/817
    • A method of measuring the concentration of a free ligand in a biological fluid containing the free ligand and ligand bound to endogenous binding agent, by the steps of(a) mixing a sample of the fluid with an analogue of the ligand, a specific binder with which the free ligand and the ligand analogue bind, and an exogenous binding agent which binds the ligand analogue but not the ligand, either the ligand analogue or the specific binder being labelled,(b) incubating the resulting mixture,(c) determining either the amount of the labelled analogue bound or the amount of labelled specific binder bound, or not bound, to the ligand analogue, and(d) correlating the determined amount to the amount of free ligand present in the sample.The method is useful to measure concentration of free thyroid hormones and other hormones in body fluids, employing antibodies specific to the ligand analogue as the exogenous binding agents.
    • PCT No.PCT / GB84 / 00220 Sec。 371日期1985年2月20日 102(e)日期1985年2月20日PCT Filed 1984年6月22日PCT公布。 公开号WO85 / 00226 1985年1月17日。一种测量含有游离配体和与内源性结合剂结合的配体的生物液体中游离配体浓度的方法,通过以下步骤:(a)将流体样品与 配体,游离配体和配体类似物结合的特异性结合剂和结合配体类似物而不是配体的外源结合剂,配体类似物或被标记的特异性结合物,(b)将所得混合物 ,(c)确定与配体类似物结合或未结合的标记的类似物结合的量或标记的特异性结合物的量,和(d)将确定的量与样品中存在的游离配体的量相关联。 该方法可用于测量体液中游离甲状腺激素和其他激素的浓度,使用对配体类似物特异的抗体作为外源性结合剂。
    • 45. 发明授权
    • Living, fast-growing thyroid cell strain, FRTL-5
    • 生活,快速生长的甲状腺细胞株,FRTL-5
    • US4608341A
    • 1986-08-26
    • US499250
    • 1983-05-31
    • Francesco S. Ambesi-Impiombato
    • Francesco S. Ambesi-Impiombato
    • C12N5/071G01N33/564G01N33/78C12N5/00C12R1/91
    • G01N33/78C12N5/0617G01N33/564C12N2500/25C12N2501/18C12N2503/00Y10S435/948
    • A fast growing, continuous, functional rat thyroid cell strain, FRTL-5, which maintains functional characteristics of iodide uptake and thyroglobulin synthesis over prolonged periods of culture is cloned from FRTL cells obtained from primary cultures of Fischer rat thyroid glands. The FRTL-5 cells are cultured in a medium containing approximately 5 percent calf serum supplemented with a mixture of hormones, at least one of which is thyrotropin.The FRTL-5 cells are employed in a series of assays which measure thyroid stimulatory or inhibitory factors. The FRTL-5 system of assay specifically measures thymidine incorporation, cAMP elevation and iodide uptake and permits the evaluation of patient sera, particularly those afflicted with Graves' disease and other autoimmune thyroid diseases, thereby providing a means for determining appropriate methods of treatment.
    • 从Fischer大鼠甲状腺原始培养物获得的FRTL细胞克隆了快速生长,连续功能的大鼠甲状腺细胞株FRTL-5,其保持长时间培养的碘摄取和甲状腺球蛋白合成的功能特征。 将FRTL-5细胞在含有补充有激素混合物的约5%小牛血清的培养基中培养,其中至少一种是促甲状腺激素。 FRTL-5细胞用于测量甲状腺刺激或抑制因子的一系列测定中。 FRTL-5分析系统特异性地测量胸苷掺入,cAMP升高和碘摄取,并允许对患者血清进行评估,特别是患有Graves病和其他自身免疫性甲状腺疾病的血清,从而提供了确定适当治疗方法的手段。
    • 49. 发明授权
    • Assay for free thyroid hormone
    • 测定游离甲状腺激素
    • US4391795A
    • 1983-07-05
    • US131934
    • 1980-03-21
    • Samuel R. Pearlman
    • Samuel R. Pearlman
    • G01N33/78G01N33/56G01N33/58G01N33/60
    • G01N33/78Y10S436/808
    • Sample containing free and bound thyroid hormone; in particular, thyroxine, is contacted with immobilized binder; in particular, supported on a solid support, to bind the free thyroxine. After separating the bound thyroxine from the immobilized binder having free thyroxine bound thereto, the immobilized binder is contacted with labeled thyroxine; in particular, radiolabeled thyroxine. Unbound labeled thyroxine is removed, and the amount of bound and/or unbound labeled thyroxine is measured, with the free thyroxine concentration in the sample being inversely proportional to the amount of labeled thyroxine bound to the immobilized binder.
    • 含有游离和结合甲状腺激素的样品; 特别是甲状腺素与固定化的粘合剂接触; 特别是支持坚定的支持,约束游离甲状腺素。 将结合的甲状腺素与结合有游离甲状腺素的固定化粘合剂分离后,将固定的粘合剂与标记的甲状腺素接触; 特别是放射性标记的甲状腺素。 去除未结合的标记的甲状腺素,测量结合和/或未结合标记的甲状腺素的量,样品中的游离甲状腺素浓度与与固定化的结合物结合的标记的甲状腺素的量成反比。
    • 50. 发明授权
    • Thyroid polarization fluoroimmunoassay
    • 甲状腺偏光荧光免疫测定
    • US4347058A
    • 1982-08-31
    • US187238
    • 1980-09-15
    • Alan J. PolitoKurtis R. Bray
    • Alan J. PolitoKurtis R. Bray
    • G01N33/78G01N33/52G01N33/54
    • G01N33/78Y10S436/80
    • A polarization fluoroimmunoassay for T.sub.3 or T.sub.4 thyroid hormones where a serum sample is assayed by contacting the sample with a base to denature the thyroxine binding globulins and thereby form a solution, incubating the solution, contacting the solution with a separating agent and separating bound thyroid hormone from the serum, contacting the separating agent with bound thyroid hormone with an antibody against the thyroid hormone, incubating the separating agent-antibody combination, separating free antibody and thyroid hormone bound antibody from the separating agent, contacting the free antibody with fluorescent labelled thyroid hormone and measuring the fluorescence polarization as an indication of the thyroid hormone in the sample.
    • 用于T3或T4甲状腺激素的偏振荧光免疫测定法,其中通过使样品与碱接触来测定血清样品,以使甲状腺素结合球蛋白变性,从而形成溶液,孵育溶液,使溶液与分离剂接触并分离结合的甲状腺激素 从血清中将分离剂与结合的甲状腺激素与抗甲状腺激素的抗体接触,孵育分离剂 - 抗体组合,从分离剂中分离游离抗体和甲状腺激素结合的抗体,使游离抗体与荧光标记的甲状腺激素接触 并测量荧光偏振作为样品中甲状腺激素的指示。